Sunitinib Teva

Sunitinib Teva is an oral prescription medication used to treat certain types of cancer. It belongs to a class of drugs that work by slowing or stopping the growth of cancer cells. This product is manufactured by Teva B.V and is available for oral use.

Sunitinib Teva is primarily used to treat gastrointestinal stromal tumors (GIST) after disease progression or intolerance to imatinib. It is also used for advanced renal cell carcinoma (kidney cancer) and progressive pancreatic neuroendocrine tumors (pNET) in adults. This medication helps manage symptoms and may slow disease progression in these conditions.

Sunitinib Teva works by targeting specific proteins in cancer cells to inhibit their growth. Patients may experience effects such as fatigue, nausea, or changes in skin color during treatment. These effects vary and should be monitored by a healthcare provider.

Sunitinib Teva should be taken exactly as prescribed by a healthcare professional. Patients should inform their doctor about all medications and supplements they are using. Regular blood tests may be required to monitor for side effects. Avoid grapefruit products while taking this medication.

Sunitinib Teva can interact with other drugs, including strong CYP3A4 inhibitors or inducers, which may affect its levels in the body. Alcohol and certain herbal supplements may also interact. Always consult a healthcare provider before combining medications or starting new treatments.